How to use capsules as a competitive advantage in a crowded pharma marketplace |
Even as innovations in novel drug delivery systems continue to emerge, oral solid dose formulations still rule the market – they are easier to manufacture, cost-effective, have good storage stability, and most importantly are widely accepted by patients.
In the next five years, more than 130 drug patents will expire, paving the way for around 35 generic solid dosage products. Of course, this will also mean stiff competition in the market. However, there is a way for generic players to set themselves apart from the competition while still remaining price sensitive.
Watch our webinar to find out about the latest developments in hard capsule technology, and how you can best use them to differentiate your products and make them more patient-centric. |
What will the webinar cover?
• Overview of drugs going off patent in the next five years.
• Overview of new oral dosage product launches in last five years.
• Opportunities for hard capsules.
• Advances in capsule technology |
Who should watch?
This webinar has been designed for:
• Formulation Scientists.
• Analytical Scientists.
• Procurement Managers.
• Business Development Managers. |
Speaker
Jnanadeva Bhat, Ph. D
Head - Formulation R&D (Pharma & Nutra), ACG Capsules
Jnanadeva has been associated with the pharmaceutical industry for more than two and a half decades. As a product formulator, he has worked on various dosage forms that include tablets, soft gelatin and hard capsules, injectables and lyophilized formulations. At ACG, he heads the formulation R&D lab where he primarily leads new product development projects. He has several technical white papers and research articles published to his credit. | | |
|
| Welcome, and thanks for clicking through. Please fill in a few simple details below, and then let us know how we can best help you. |
|
|
|
|
|